- Previous Close
3.3900 - Open
3.5400 - Bid 3.4800 x 40000
- Ask 3.5400 x 40000
- Day's Range
3.5400 - 3.5400 - 52 Week Range
2.0500 - 4.6700 - Volume
600 - Avg. Volume
53,429 - Market Cap (intraday)
1.275B - Beta (5Y Monthly) 0.24
- PE Ratio (TTM)
16.09 - EPS (TTM)
0.2200 - Earnings Date Nov 14, 2024 - Nov 18, 2024
- Forward Dividend & Yield 0.10 (2.84%)
- Ex-Dividend Date Jun 14, 2024
- 1y Target Est
--
Life Healthcare Group Holdings Limited, together with its subsidiaries, operates as a private healthcare company in Southern Africa. It also operates as a research and development pharmaceutical company in the United Kingdom, Europe, the United States, and internationally. The company operates acute hospitals. It also offers mental health, acute rehabilitation, renal dialysis, oncology, and imaging services. In addition, the company provides long-term services for patients requiring frail care, chronic mental healthcare, and substance abuse support; wellness programs, and occupational and primary healthcare to corporate and institutional clients; and contracted on-site occupational, primary, and emergency healthcare services to large private and public employees. Further, it develops and commercializes molecular imaging agents for use in positron emission computerized tomography diagnostics. The company was formerly known as Afrox Healthcare Limited and changed its name to Life Healthcare Group Holdings Limited in January 2005. Life Healthcare Group Holdings Limited was founded in 1983 and is headquartered in Johannesburg, South Africa.
www.lifehealthcare.co.za--
Full Time Employees
September 30
Fiscal Year Ends
Sector
Industry
Recent News: LTGHY
View MorePerformance Overview: LTGHY
Trailing total returns as of 9/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: LTGHY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: LTGHY
View MoreValuation Measures
Market Cap
1.29B
Enterprise Value
950.14M
Trailing P/E
16.17
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.97
Price/Book (mrq)
1.98
Enterprise Value/Revenue
0.71
Enterprise Value/EBITDA
4.43
Financial Highlights
Profitability and Income Statement
Profit Margin
13.54%
Return on Assets (ttm)
3.91%
Return on Equity (ttm)
9.30%
Revenue (ttm)
23.76B
Net Income Avi to Common (ttm)
1.41B
Diluted EPS (ttm)
0.2200
Balance Sheet and Cash Flow
Total Cash (mrq)
10.15B
Total Debt/Equity (mrq)
33.12%
Levered Free Cash Flow (ttm)
9.43B